Clinical Trials in Netherlands — Country Dashboard | 2,584 EU Studies

Filter these 2,584 trials by condition, phase, sponsor and more.

Open in Search →

2,584 Registered trials

1,062 Recruiting

1,246 Completed trials

647 Sponsors active

360 Research sites

Phase III

Phase II

Phase III: 959 Phase II/III: 112 Phase II: 572 Phase I/II: 138 Phase III/IV: 55 Phase IV: 244 Phase I: 165 Phase I (Other): 215 Phase I (FiH): 110 Other: 13 Other: 1

Oversight events in trials active here:

116 serious breaches 513 temporary halts 35 urgent safety measures 70 unexpected events 90 corrective measures across 317 trials

View oversight register →

Top conditions

Non-small cell lung cancer 86 Non-small cell lung cancer metastatic 24 Amyotrophic lateral sclerosis 22 Crohn's disease 19 Prostate cancer metastatic 18 Colorectal cancer 17 Obesity 17 Colitis ulcerative 16 Diffuse large B-cell lymphoma 14 Systemic lupus erythematosus 13 Pulmonary arterial hypertension 13 Endometrial cancer 12

Top sponsors

Amsterdam UMC Stichting 102 Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 94 Novartis Pharma AG 90 Merck Sharp & Dohme LLC 80 AstraZeneca AB 77 Universitair Medisch Centrum Groningen 70 F. Hoffmann-La Roche AG 64 Janssen - Cilag International 62 Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting 51 Radboud universitair medisch centrum Stichting 51 Boehringer Ingelheim International GmbH 50 Amsterdam UMC 47

Cities with most trials

All 123 cities →

All trials — page 5

2,584 total

RESET-TRD; a Randomised trial on oral ESketamine compared to Electroconvulsive Therapy for patients with Treatment Resistant Depression Pending

2024-517485-42-00 Phase III Non-psychotic therapy resistant unipolar depression Universitair Medisch Centrum Groningen
A PHASE II OPEN-LABEL STUDY OF UM171-EXPANDED CORD BLOOD TRANSPLANTATION IN PATIENTS WITH HIGH AND VERY HIGH-RISK ACUTE LEUKEMIA/MYELODYSPLA… Pending

2024-517583-36-01 Phase II High risk and very high risk acute leukemia/myelodysplasia r… Excellthera Inc.
Adoptive TIL therapy in combination with chemoimmunotherapy in advanced NSCLC patients Pending

2024-517939-53-00 Phase I Respiratory tract diseases Leids Universitair Medisch Centrum (LUMC)
A randomized trial of systemic chemotherapy with or without hepatic arterial infusion pump chemotherapy for patients with inoperable bile du… Pending

2024-518065-10-00 Phase II Unresectable intrahepatic cholangiocarcinoma Memorial Sloan Kettering Cancer Center
Colchicine to inhibit atherosclerosis in patients with cancer receiving immune therapy Pending

2024-518100-45-00 Phase III Atherosclerosis Amsterdam UMC Stichting
Effects and health economic aspects of enzyme therapy in children and adults with Pompe disease Pending

2024-518269-92-00 Phase IV Pompe disease / glycogenosis type II / acid maltase deficien… Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infe… Pending

2024-518420-80-00 Phase III Primary infection prophylaxis for secondary immunodeficiency… Takeda Development Center Americas Inc.
Chemo-immunotherapy before and after surgery for peritoneal metastases of large bowel cancer. Pending

2024-518570-13-00 Phase II/III Resectable peritoneal metastases of a colorectal origin Catharina Ziekenhuis Stichting
A Phase 2 Study to Evaluate the Efficacy and Safety of Ampligen® Compared to Control Group / No Treatment Following FOLFIRINOX in Subjects w… Pending

2024-518627-29-00 Phase II locally advanced pancreatic cancer Aim Immunotech Inc.
Randomized controlled trial comparing immediate versus extended release tacrolimus; reducing calcineurin inhibitor related toxicity in lung … Pending

2024-518639-12-00 Phase III lung transplantation Universitair Medisch Centrum Groningen
ESTIS trial: Early Stop of targeted Treatment in children with Systemic JIA. Pending

2024-518684-35-00 Phase IV autoimmune disorders, joint disorders synonym: Still's disea… Universitair Medisch Centrum Utrecht
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults with Non-cystic Fibrosis Bronchiectasis (NCFB) Pending

2024-518821-13-00 Phase II Non-cystic Fibrosis Bronchiectasis CSL Behring LLC
Comparison of two treatments (intrathecal baclofen pump and selective dorsal rhizotomy) for children with cerebral palsy who cannot walk Pending

2024-518822-33-01 Phase IV Cerebral Palsy UZ Leuven
Evaluation of [18F]MC225 to measure P-glycoprotein function in neurodegenerative disease Pending

2024-518865-85-00 Phase II Alzheimers Disease Universitair Medisch Centrum Groningen
The FIND study Pending

2024-518908-46-00 Phase III ACTH-dependent hypercortisolism Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
GRoningen Early-PD Ambroxol Treatment Pharmacokinetics Pending

2024-519088-16-01 Phase I (Other) Parkinson's disease Universitair Medisch Centrum Groningen
A PHASE 1 STUDY WITH SINGLE ASCENDING DOSE, MULTIPLE ASCENDING DOSE AND FOOD EFFECT OF LMT503 IN HEALTHY SUBJECTS. Pending

2024-519180-17-00 Phase I Healthy volonteers Lmito Therapeutics Inc.
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy with Standard-of-Care Combination Regimens … Pending

2024-519504-27-00 Phase III Relapsed Refractory Multiple Myeloma Regeneron Pharmaceuticals Inc.
IMMUNOPEC: Combination of neo-adjuvant Checkpoint Inhibition and Dendritic Cell Therapy (MesoPher) with Cytoreductive Surgery and Hypertherm… Pending

2024-519626-21-00 Phase II Peritoneal Mesothelioma Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Weight-loss Effects aNd absorption of Direct oral anticoagulants in roux-en-Y gastric bypass patients: a prospective study (WENDY) Pending

2024-519737-30-00 Phase IV Roux-en-Y gastric bypass Amsterdam UMC Stichting
MEDFAST-study Pending

2024-519774-40-00 Phase IV People with a Body Mass Index (BMI) of 30 kg/m2 or more (obe… Sint Franciscus Vlietland Groep Stichting
A Phase Ib/II Open-Label, Multicentre Platform Study Evaluating Novel Combinations in Participants with Advanced or Metastatic Non-Small Cel… Pending

2024-519786-22-01 Phase I/II metastatic non-small cell lung cancer (NSCLC) AstraZeneca AB
A trial to learn how well sonesitatug vedotin and capecitabine with or without rilvegostomig work and how safe they are in adults with cance… Pending

2024-519787-40-00 Phase III Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Es… AstraZeneca AB
EPABID: Efficacy of Pipamperone and Aripiprazole on Behaviors that challenge in Intellectual Disabilities Pending

2024-519833-51-00 Phase IV Behaviors that challenge Stichting GGZ Drenthe

Showing 97–120 of 2,584 trials

← All countries